Rifat Pamukcu serves as Executive at Aprea Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rifat Pamukcu has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 20, 2024 involved receiving (via award) 1,045 shares valued at $0.
Rifat Pamukcu currently holds 4,401 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rifat Pamukcu has been a net neutral trader of APRE stock. They have purchased $0 and sold $0 worth of shares.
Rifat Pamukcu's most recent insider trade was on Jun 20, 2024, when they sold 1,045 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 23, 2022 | APRE | $0 | Conversion | 271,870 | $N/A | Discretionary |
| Aug 23, 2022 | APRE | $0 | Conversion | 49,280 | $N/A | Discretionary |
| Jul 28, 2022 | APRE | $0 | Award | 5,995 | $N/A | Discretionary |